Secondary Antibiotic Prophylaxis for Latent Rheumatic Heart Disease

Rheumatic heart disease affects more than 40.5 million people worldwide and results in 306,000 deaths annually. Echocardiographic screening detects rheumatic heart disease at an early, latent stage. Whether secondary antibiotic prophylaxis is effective in preventing progression of latent rheumatic heart disease is unknown. METHODSWe conducted a randomized, controlled trial of secondary antibiotic prophylaxis in Ugandan … Continue reading Secondary Antibiotic Prophylaxis for Latent Rheumatic Heart Disease